The summary below is from the full report titled “Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab. A Randomized Trial.” It is in the 19 June 2007 issue of Annals of Internal Medicine (volume 146, pages 829-838). The authors are W.J. Sandborn, P. Rutgeerts, R. Enns, S.B. Hanauer, J.-F. Colombel, R. Panaccione, G. D'Haens, J. Li, M.R. Rosenfeld, J.D. Kent, and P.F. Pollack.
Treatment of Crohn Disease with Anti–Tumor Necrosis Factor Agent. Ann Intern Med. 2007;146:I–20. doi: https://doi.org/10.7326/0003-4819-146-12-200706190-00160
Download citation file:
Published: Ann Intern Med. 2007;146(12):I-20.
Gastroenterology/Hepatology, Inflammatory Bowel Disease.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use